New transplant approach aims to beat blood cancer with fewer side effects

NCT ID NCT05417971

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study tests a less intense stem cell transplant for people with blood cancers like leukemia or lymphoma. The treatment uses chemotherapy and radiation before receiving donor stem cells from a partially matched family member. The goal is to help the body accept the new cells and control the cancer, though ongoing monitoring and possible medications are still needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Caitlin Guzowski

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.